Search
Home
Cardiology
Diabetes/Endocrinology
General Medicine
HIV/Infectious Diseases
Neurology
Oncology
Pulmonary Medicine
ADVERTISEMENT
Coverage from the
American Diabetes Association (ADA) 2021
Read clinically focused news coverage of key developments from ADA 2021
Conference Report
Testosterone Therapy for Hypogonadism With Diabetes?
2 August 2021
ADA 2021
Diabetes/Endocrinology
Conference Report
New Agents for Youth-Onset Type 2 Diabetes 'Finally in Sight'
13 July 2021
ADA 2021
Diabetes/Endocrinology
Type 2 Diabetes
Conference Report
Insulin-Pramlintide Combo Improves Type 1 Diabetes Control
6 July 2021
ADA 2021
Diabetes/Endocrinology
Type 1 Diabetes
Continue Reading Below
ADVERTISEMENT
Conference Report
Anti-VEGF injections for diabetic retinopathy linked to mortality risk
1 July 2021
ADA 2021
Diabetes/Endocrinology
Type 2 Diabetes
Conference Report
ADA 2021 — Short-term cotadutide treatment holds promise in patients with T2D and DKD
1 July 2021
ADA 2021
Chronic Kidney Disease
Diabetes/Endocrinology
General Medicine
Type 2 Diabetes
Vaccination
Conference Report
ADA 2021 — T2D with HF or CKD: SOLOIST and SCORED trials highlight early benefits of sotagliflozin
1 July 2021
ADA 2021
Acute Coronary Syndromes (ACS)
Cardiology
Chronic Kidney Disease
Diabetes/Endocrinology
General Medicine
Heart Failure
Neurology
Stroke/Cerebrovascular Disease
Type 2 Diabetes
Vaccination
Conference Report
What's Best for Diabetes After Metformin? GRADE Outdated at Outset
30 June 2021
ADA 2021
Diabetes/Endocrinology
Type 2 Diabetes
Conference Report
ADA 2021 — Significant rise in pediatric new-onset T2D incidence during the COVID-19 pandemic
30 June 2021
ADA 2021
COVID-19
Diabetes/Endocrinology
General Medicine
Type 1 Diabetes
Type 2 Diabetes
Vaccination
Conference Report
ADA 2021 — Unmanaged diabetes tied to poor COVID-19 outcomes
30 June 2021
ADA 2021
COVID-19
Diabetes/Endocrinology
General Medicine
HIV/Infectious Diseases
Sepsis
Vaccination
Conference Report
ADA 2021 — Dapagliflozin well tolerated in patients hospitalized with COVID-19, regardless of diabetes status
30 June 2021
ADA 2021
COVID-19
Cardiology
Diabetes/Endocrinology
General Medicine
HIV/Infectious Diseases
Heart Failure
Pulmonary Medicine
Type 2 Diabetes
Vaccination
Conference Report
ADA 2021 — Finerenone beneficial in patients with T2D and CKD, irrespective of SGLT2i use
30 June 2021
ADA 2021
Acute Coronary Syndromes (ACS)
Cardiology
Chronic Kidney Disease
Diabetes/Endocrinology
General Medicine
Heart Failure
Hypertension
Stroke/Cerebrovascular Disease
Type 2 Diabetes
Vaccination
Conference Report
ADA 2021 — T2D: weekly efpeglenatide significantly reduces risk for cardiovascular events
30 June 2021
ADA 2021
Cardiology
Cardiovascular Risk Reduction
Diabetes/Endocrinology
General Medicine
Type 2 Diabetes
Vaccination
Conference Report
ADA 2021 — T2D: tirzepatide vs semaglutide as an add-on to metformin
30 June 2021
ADA 2021
Diabetes/Endocrinology
General Medicine
Obesity and Weight Management
Type 2 Diabetes
Vaccination
Conference Report
AMPLITUDE-O: Efpeglenatide Benefits in High-Risk Diabetes
29 June 2021
ADA 2021
Diabetes/Endocrinology
Type 2 Diabetes
Continue Reading Below
Conferences
View all
European Association for the Study of Diabetes (EASD) - 2022
Immuno-Oncology Congress (ESMO) 2022
International Congress of the European Respiratory Society (ERS) 2022
European Society of Cardiology (ESC) 2022
International AIDS Society (IAS) Conference 2022
The Endocrine Society (ENDO) 2022
American Diabetes Association (ADA) 2022
American Society of Clinical Oncology (ASCO) 2022
European Atherosclerosis Society Congress (EAS) 2022
European Congress on Obesity (ECO) 2022
View all